指南与共识肺结节与肺癌

肺癌筛查:CHEST指南与专家小组报告

Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
指南 / 共识 · Chest · 2018-02-17

该指南基于系统综述(59项研究)回答12个PICO问题,形成6条分级推荐和9条未分级共识声明。证据表明低剂量CT筛查的获益与危害平衡有利但脆弱,受筛查人群选择、影像质量、结果管理及戒烟干预效果影响。

要点

  • 低剂量CT筛查获益与危害平衡有利但脆弱,需重视筛查人群选择。
  • 影像质量、结果管理及戒烟干预效果可影响筛查净获益。
  • 指南形成6条分级推荐和9条未分级共识声明指导实践。

核心结论

  • 低剂量CT筛查的获益与危害平衡有利但脆弱,需优化筛查各环节。

研究设计与样本

  • 专家小组以PICO格式提出关键问题,系统检索MEDLINE、Embase和Cochrane Library,用GRADE评估证据质量,经投票达成共识。
  • 系统综述纳入59项研究,回答12个PICO问题,形成6条分级推荐和9条未分级共识声明。

主要发现

  • 系统综述识别59项研究,回答12个PICO问题,形成6条分级推荐和9条未分级共识声明。
  • 低剂量CT筛查的获益与危害在频率和程度上不同,净平衡有利但脆弱。

关键数值与推荐

  • 6条分级推荐和9条未分级共识声明(具体条款未在摘要中列出)。

临床怎么用

  • 筛查实践需关注筛查合格人群选择、影像质量与判读、筛查发现的管理及戒烟干预效果。

局限性

  • 部分推荐基于经验与专家共识而非证据;需进一步研究优化低剂量CT筛查方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low-dose chest CT screening for lung cancer has become a standard of care in the United States in the past few years, in large part due to the results of the National Lung Screening Trial. The benefit and harms of low-dose chest CT screening differ in both frequency and magnitude. The translation of a favorable balance of benefit and harms into practice can be difficult. Here, we update the evidence base for the benefit, harms, and implementation of low radiation dose chest CT screening. We use the updated evidence base to provide recommendations where the evidence allows, and statements based on experience and expert consensus where it does not. METHODS: Approved panelists developed key questions using the PICO (population, intervention, comparator, and outcome) format to address the benefit and harms of low-dose CT screening, as well as key areas of program implementation. A systematic literature review was conducted by using MEDLINE via PubMed, Embase, and the Cochrane Library. Reference lists from relevant retrievals were searched, and additional papers were added. The quality of the evidence was assessed for each critical or important outcome of interest using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach. Important clinical questions were addressed based on the evidence developed from the systematic literature review. Graded recommendations and ungraded statements were drafted, voted on, and revised until consensus was reached. RESULTS: The systematic literature review identified 59 studies that informed the response to the 12 PICO questions that were developed. Key clinical questions were addressed resulting in six graded recommendations and nine ungraded consensus based statements. CONCLUSIONS: Evidence suggests that low-dose CT screening for lung cancer results in a favorable but tenuous balance of benefit and harms. The selection of screen-eligible patients, the quality of imaging and image interpretation, the management of screen-detected findings, and the effectiveness of smoking cessation interventions can affect this balance. Additional research is needed to optimize the approach to low-dose CT screening.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Mazzone PJ, Silvestri GA, Patel S, et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2018. PMID: 29374513. doi:10.1016/j.chest.2018.01.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。